Funding

New Funding Opportunities

Notice Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R01 Clinical Trials Not Allowed)
Notice Number PAR-20-165
Post Date April 13, 2020
Expiration Date March 6, 2023
Notice Research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (R21 Clinical Trials Not Allowed)
Notice Number PAR-20-168
Post Date April 13, 2020
Expiration Date May 8, 2023

Past Funding Opportunities

Notice Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54, Basic Experimental Studies Involving Humans Allowed)
Notice Number RFA-NS-22-019
Notice Data Management and Coordinating Center (DMCC) for the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRC) (U24 Basic Experimental Studies with Humans Required)
Notice Number RFA-NS-22-020
Notice Clinical Validation of a Candidate Biomarker for Neurological Disease (U01 Clinical Trial Optional)
Notice Number PAR-18-664
Notice Analytical Validation of a Candidate Biomarker for Neurological Disease (U01) (Clinical Trial Optional)
Notice Number PAR-18-550
Notice Analytical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional)
Notice Number PAR-18-549
Notice Clinical Validation of a Candidate Biomarker for Neurological Disease (U44 Clinical Trial Optional)
Notice Number PAR-18-548

This page last reviewed on August 19, 2022